Wolverine Trading, LLC Novavax Inc Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $21,420 - $34,220	2,000 Added 1.49%	136,500 $1.72 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $313,923 - $1.69 Million	80,700 Added 150.0%	134,500 $1.7 Million
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $202,288 - $323,876	53,800 New	53,800 $257,000
Q3 2023 Nov 15, 2023	BUY	$6.81 - $9.74 $797,451 - $1.14 Million	117,100 New	117,100 $847,000
Q1 2023 May 15, 2023	BUY	$5.76 - $12.48 $107,136 - $232,128	18,600 Added 19.68%	113,100 $745,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $837,270 - $2.37 Million	94,500 New	94,500 $971,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $747,368 - $1.55 Million	-20,600 Reduced 16.41%	104,900 $5.44 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $3.72 Million - $7.62 Million	-53,300 Reduced 29.81%	125,500 $9.38 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1.06 Million - $1.72 Million	7,900 Added 4.62%	178,800 $27.7 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $5.55 Million - $8.44 Million	31,200 Added 22.33%	170,900 $34.8 Million
Q2 2021 Aug 06, 2021	BUY	$121.0 - $257.67 $5.06 Million - $10.8 Million	41,800 Added 42.7%	139,700 $29.2 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $2.84 Million - $8.03 Million	-25,100 Reduced 20.41%	97,900 $17 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $2.31 Million - $4.1 Million	29,400 Added 31.41%	123,000 $14.6 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $643,464 - $1.45 Million	8,100 Added 9.47%	93,600 $10.1 Million
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $383,922 - $2.32 Million	27,700 Added 47.92%	85,500 $7.15 Million
Q1 2020 May 11, 2020	BUY	$3.93 - $16.0 $227,154 - $924,800	57,800 New	57,800 $827,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $676M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account